Bactrim: Potent Dual-Antibiotic Therapy for Complex Infections
Bactrim
| Product dosage: 480mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.46 | $41.00 (0%) | 🛒 Add to cart |
| 120 | $0.42 | $54.67 $50.00 (9%) | 🛒 Add to cart |
| 180 | $0.38 | $82.00 $68.00 (17%) | 🛒 Add to cart |
| 270 | $0.36 | $123.00 $97.00 (21%) | 🛒 Add to cart |
| 360 | $0.34
Best per pill | $164.00 $121.00 (26%) | 🛒 Add to cart |
Bactrim is a powerful, combination antibiotic medication containing sulfamethoxazole and trimethoprim. This synergistic formulation is designed to target a broad spectrum of susceptible bacterial strains by inhibiting two consecutive steps in the biosynthesis of nucleic acids and proteins essential to bacterial growth. It is a cornerstone in the treatment of various moderate to severe bacterial infections, particularly those resistant to single-agent antibiotics. Its clinical utility spans hospital, outpatient, and prophylactic settings, making it a versatile agent in the infectious disease arsenal.
Features
- Dual-Action Formula: Contains sulfamethoxazole and trimethoprim for sequential blockade of bacterial folate metabolism.
- Broad-Spectrum Coverage: Effective against both Gram-positive and Gram-negative bacteria, including Staphylococcus aureus, Escherichia coli, Klebsiella species, Enterobacter species, Haemophilus influenzae, and Streptococcus pneumoniae.
- Multiple Formulations: Available in oral tablets (standard and double strength), oral suspension, and intravenous injection for flexible administration.
- High Bioavailability: Oral formulations are well-absorbed from the gastrointestinal tract, achieving therapeutic serum concentrations within 2-4 hours post-administration.
- Established Safety Profile: Decades of clinical use with well-documented pharmacokinetic and pharmacodynamic data.
Benefits
- Enhanced Bactericidal Activity: The dual-mechanism action reduces the potential for bacterial resistance development compared to single-agent therapies.
- Effective for Resistant Infections: Particularly valuable for treating infections caused by multidrug-resistant organisms, such as methicillin-resistant Staphylococcus aureus (MRSA) in certain contexts.
- Rapid Onset of Action: Achieves therapeutic concentrations quickly, facilitating prompt clinical improvement in acute infections.
- Prophylactic Efficacy: Proven to reduce the frequency of attacks in chronic conditions like recurrent urinary tract infections and Pneumocystis jirovecii pneumonia in immunocompromised patients.
- Convenient Dosing Regimen: Typically administered twice daily, supporting adherence and outpatient management.
- Cost-Effective Treatment: Generic availability makes it an economically viable option for long-term or high-volume use.
Common use
Bactrim is indicated for the treatment of a variety of bacterial infections due to susceptible strains of designated microorganisms. Its primary uses include urinary tract infections (acute, recurrent, and chronic), acute otitis media in children, acute exacerbations of chronic bronchitis in adults, traveler’s diarrhea, and shigellosis. It is also a first-line agent for the treatment and prophylaxis of Pneumocystis jirovecii pneumonia (PCP), particularly in patients with HIV/AIDS or other immunocompromising conditions. Off-label uses may include treatment of certain skin and soft tissue infections, nocardiosis, and toxoplasmosis.
Dosage and direction
Dosage must be individualized based on the type and severity of infection, renal function, and patient factors. For most infections in adults and children over 2 months, the standard dosage is based on the trimethoprim component: 8-10 mg/kg/day (trimethoprim) in two to four divided doses. For urinary tract infections and shigellosis in adults, one double-strength tablet (160 mg trimethoprim/800 mg sulfamethoxazole) every 12 hours for 10-14 days is common. For PCP treatment: 15-20 mg/kg/day (trimethoprim) in three to four divided doses for 14-21 days. For prophylaxis: one double-strength tablet daily or three times per week. In patients with renal impairment (CrCl <30 mL/min), dosage reduction is necessary. Tablets should be taken with a full glass of water, and adequate fluid intake maintained to prevent crystalluria.
Precautions
Use with caution in patients with renal or hepatic impairment, severe allergies, or bronchial asthma. Monitor renal function and electrolytes during therapy. May cause folate deficiency; consider leucovorin supplementation in prolonged therapy. Use in pregnancy only if potential benefit justifies potential risk to fetus (Category D). Not recommended during lactation due to secretion in breast milk and potential for kernicterus in infants. Can cause photosensitivity; advise patients to use sunscreen and protective clothing. Regular blood counts are recommended during prolonged therapy due to risk of hematologic toxicity.
Contraindications
Hypersensitivity to sulfamethoxazole, trimethoprim, or any sulfonamide-derived drugs. Documented megaloblastic anemia due to folate deficiency. Marked renal impairment (CrCl <15 mL/min). Pregnancy at term and during the nursing period. Infants less than 2 months of age. Concomitant use with dofetilide.
Possible side effect
Common adverse reactions include nausea, vomiting, anorexia, and rash. More serious but less frequent side effects may include Stevens-Johnson syndrome, toxic epidermal necrolysis, agranulocytosis, aplastic anemia, thrombocytopenia, leukopenia, hemolytic anemia, hyperkalemia, hyponatremia, hepatitis, jaundice, pseudomembranous colitis, and interstitial nephritis. Allergic reactions ranging from urticaria to anaphylaxis may occur. Photosensitivity, dizziness, headache, and insomnia have also been reported.
Drug interaction
Bactrim may potentiate the effects of warfarin, phenytoin, and oral hypoglycemics. It may increase cyclosporine levels and nephrotoxicity. Concurrent use with ACE inhibitors or ARBs may increase risk of hyperkalemia. It may decrease the efficacy of oral contraceptives. Concomitant use with methotrexate increases hematologic toxicity. Thiazide diuretics may increase risk of thrombocytopenia. Pyrimethamine may increase risk of megaloblastic anemia. Concomitant use with dofetilide is contraindicated due to risk of fatal arrhythmias.
Missed dose
If a dose is missed, it should be taken as soon as remembered. However, if it is almost time for the next dose, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. Maintaining consistent antibiotic levels is crucial for efficacy and resistance prevention.
Overdose
Symptoms of overdose may include nausea, vomiting, dizziness, headache, mental depression, confusion, and bone marrow depression. In severe cases, jaundice, crystalluria, hematuria, and electrolyte imbalances may occur. Treatment is supportive and symptomatic. Maintain hydration and urinary output to prevent crystalluria. Hemodialysis may be moderately effective in removing both components. Leucovorin may be administered to reverse folate antagonism.
Storage
Store at room temperature (20-25°C or 68-77°F), in a tight, light-resistant container. Keep away from moisture and heat. Do not freeze the oral suspension. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment recommendations. Do not initiate, discontinue, or change dosage of any medication without professional supervision. The prescribing information provided here may not be exhaustive or current.
Reviews
(Note: As an AI, I do not have access to real-time patient reviews. In a clinical context, Bactrim is generally regarded as a highly effective antibiotic for indicated uses. Professional consensus praises its broad-spectrum activity and utility in resistant infections, though notes its side effect profile requires careful patient selection and monitoring. Patient experiences vary, with many reporting rapid resolution of symptoms, while others note gastrointestinal discomfort or skin reactions. Always refer to peer-reviewed literature and clinical guidelines for authoritative assessments.)